Literature DB >> 11403350

Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma.

V Gardet1, B Gatta, G Simonnet, A Tabarin, G Chêne, D Ducassou, J B Corcuff.   

Abstract

OBJECTIVE: To audit the performances of the analytes used in the diagnosis of pheochromocytoma and to present a graphical guideline to help the diagnosis.
DESIGN: A 5 year retrospective study. SETTINGS: Laboratory and departments of a university hospital. PARTICIPANTS: In-patients, suspected of bearing a pheochromocytoma, were investigated for urinary metanephrines and catecholamines (photometric method) and vanillylmandelic acid, fractionated catecholamines and metanephrines [high pressure liquid chromatography (HPLC) coupled to electrochemical detection (ED)] urinary excretion. MAIN OUTCOME: Patients with a pheochromocytoma (24 out of 2003 patients) were diagnosed by the combination of normetanephrine and metanephrine determination.
RESULTS: All analytes but dopamine were significantly elevated in patients with a pheochromocytoma. The area under the receiver operating characteristics (ROC) curves were the highest for total metanephrines, normetanephrine and metanephrine determinations. Because of analytical interferences in the metanephrines determination, the normetanephrine and metanephrine performed better. It is noteworthy that all pheochromocytomas had either normetanephrine or metanephrine levels above their respective optimal threshold (sensitivity 100%). The best optimal threshold performance was reached by the mean of three daily samples. Total or fractionated catecholamines or vanillylmandelic acid were less accurate tools.
CONCLUSION: Amongst urinary tests, the combined use of HPLC/ED determination of normetanephrine and metanephrine seems the most effective screening strategy for the diagnosis of pheochromocytoma. The older total metanephrine photometric assay is grieved by analytical interferences.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403350     DOI: 10.1097/00004872-200106000-00006

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  9 in total

1.  Comparative values of catecholamines and metabolites for the diagnosis of neuroblastoma.

Authors:  Maud Monsaingeon; Yves Perel; Guy Simonnet; Jean-Benoît Corcuff
Journal:  Eur J Pediatr       Date:  2003-03-27       Impact factor: 3.183

2.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

Review 3.  Choice of biochemical test for diagnosis of pheochromocytoma: validation of plasma metanephrines.

Authors:  Graeme Eisenhofer; Jacques W M Lenders; Karel Pacak
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

4.  Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population.

Authors:  Keith L Brain; Jonathan Kay; Brian Shine
Journal:  Clin Chem       Date:  2006-09-21       Impact factor: 8.327

Review 5.  Multiple endocrine neoplasia type 2.

Authors:  Mariola Peczkowska; Andrzej Januszewicz
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

6.  Pheochromocytoma: Positive predictive values of mildly elevated urinary fractionated metanephrines in a large cohort of community-dwelling patients.

Authors:  Dania Hirsch; Alon Grossman; Varda Nadler; Sandra Alboim; Gloria Tsvetov
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-05       Impact factor: 3.738

7.  A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma.

Authors:  Anna M Sawka; Ally PH Prebtani; Lehana Thabane; Amiram Gafni; Mitchell Levine; William F Young
Journal:  BMC Endocr Disord       Date:  2004-06-29       Impact factor: 2.763

Review 8.  Current Diagnostic Status of Pheochromocytomaand Future Perspective: A Mini Review.

Authors:  Fatemeh Khatami; Seyed Mohammad Tavangar
Journal:  Iran J Pathol       Date:  2017-07-01

Review 9.  Urinary sampling for 5HIAA and metanephrines determination: revisiting the recommendations.

Authors:  Jean-Benoît Corcuff; Laurence Chardon; Ines El Hajji Ridah; Julie Brossaud
Journal:  Endocr Connect       Date:  2017-05-31       Impact factor: 3.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.